Invesco S&P SmallCap Momentum ETF
XSMO - ETF AI Analysis
Top Page
Invesco S&P SmallCap Momentum ETF (XSMO)
XSMO, the Invesco S&P SmallCap Momentum ETF, earns a solid overall rating thanks to strong contributors like Alkermes, International Seaways, and Matson, which combine robust financial performance, attractive or reasonable valuations, and generally positive outlooks. These strengths are partly offset by weaker names such as Madison Square Garden Sports, where negative profitability and high leverage weigh on quality, and by several holdings with high valuations or leverage that add risk. The main risk factor is the fund’s focus on small-cap momentum stocks, which can be more volatile and sensitive to shifts in market sentiment and company fundamentals.
XSMO vs. SPDR S&P 500 ETF (SPY)
- AUM
- 2.74B
- Region
- North America
- Expense Ratio
- 0.35%
- Beta
- 0.88
- Issuer
- Invesco
- Inception Date
- Mar 03, 2005
- Dividend Yield
- 0.63%
- Asset Class
- Equity
- Index Tracked
- S&P SmallCap 600 Momentum Index
XSMO Summary
XSMO is the Invesco S&P SmallCap Momentum ETF, which follows the S&P SmallCap 600 Momentum Index. It focuses on smaller U.S. companies whose stock prices have been rising strongly. The fund spreads your money across many industries, including health care, technology, and financials, with holdings like ViaSat and Victoria’s Secret. Someone might invest in XSMO to tap into the growth potential of small, fast-moving companies and to diversify beyond large, well-known stocks. A key risk is that small-cap momentum stocks can be very volatile, so the ETF’s value can go up and down sharply with market swings.
How much will it cost me?
XSMO has an expense ratio of 0.35%, which means you’ll pay about $3.50 per year for every $1,000 invested. This cost is a bit higher than the average broad stock index ETF because XSMO tracks a specialized small-cap momentum index rather than a plain-vanilla market index.
What would affect this ETF?
XSMO could benefit if the U.S. economy stays healthy, interest rates eventually ease, and investors favor smaller, faster-growing companies, which would support its U.S. small-cap focus and momentum strategy, especially in health care, technology, and financial stocks. On the downside, higher-for-longer interest rates, an economic slowdown, or market swings away from small caps and momentum-driven names could hurt performance, and company-specific setbacks in top holdings like ViaSat, Victoria’s Secret, and Protagonist Therapeutics could add extra volatility.
XSMO Top 10 Holdings
XSMO is leaning hard into U.S. small-cap momentum, with a noticeable tilt toward health care and niche tech names. Glaukos and ViaSat are two of the fund’s main engines right now, both showing strong, rising trends that fit the momentum story perfectly. Victoria’s Secret and Matson add steady consumer and industrial exposure, quietly supporting returns. On the flip side, MaxLinear is volatile but still net positive, while MSG Knickerbockers is clearly lagging and acting as a speed bump. Overall, the fund is concentrated in U.S. small caps with a growth-and-momentum flavor.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 VSAT | ViaSat | 4.45% | $123.90M | $10.42B | 97.10% | 56Neutral |
 VSXY | Victoria's Secret | 3.75% | $104.57M | $8.83B | 214.15% | 71Outperform |
 PTGX | Protagonist Therapeutics | 2.82% | $78.66M | $8.89B | 57.62% | 68Neutral |
 LGND | Ligand Pharma | 2.23% | $62.00M | $6.28B | 51.81% | 60Neutral |
 RHP | Ryman | 2.12% | $58.97M | $9.56B | 46.58% | 66Neutral |
 MSGK | MSG Knickerbockers | 1.92% | $53.34M | $7.63B | 47.07% | 45Neutral |
 ALKS | Alkermes | 1.86% | $51.95M | $7.81B | 41.64% | 80Outperform |
 MATX | Matson | 1.76% | $49.09M | $6.13B | 95.49% | 77Outperform |
 INSW | International Seaways | 1.81% | $50.45M | $5.03B | 90.50% | 72Outperform |
 OUT | Outfront Media | 1.85% | $51.47M | $5.79B | 60.56% | 69Neutral |
XSMO Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XSMO, the sentiment is Positive. The current price of 81.42 is above the 20-day moving average (MA) of 79.91, below the 50-day MA of 81.49, and below the 200-day MA of 83.28, indicating a neutral trend. The MACD of -0.47 indicates Negative momentum. The RSI at 53.16 is Neutral, neither overbought nor oversold. The STOCH value of 69.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XSMO.
XSMO Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| XSMO | $81.42 | $84.00(3.17% Upside) | $2.74B | 0.35% | 67Neutral |
 FNDA | $36.58 | $42.87(17.19% Upside) | $8.98B | 0.25% | 67Neutral |
 FESM | $46.08 | $58.48(26.92% Upside) | $6.85B | 0.28% | 64Neutral |
 SMLF | $86.56 | $106.57(23.12% Upside) | $4.26B | 0.15% | 66Neutral |
 VIOO | $132.41 | $159.45(20.42% Upside) | $4.18B | 0.07% | 66Neutral |
 CALF | $58.22 | $65.87(13.14% Upside) | $3.86B | 0.59% | 65Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| XSMO | Invesco S&P SmallCap Momentum ETF | 81.42 | 10.98 | 15.59% | |
| FNDA | Schwab Fundamental US Small Co. Index ETF | 36.58 | 6.51 | 21.66% | |
| FESM | Fidelity Enhanced Small Cap ETF | 46.08 | 10.16 | 28.28% | |
| SMLF | iShares MSCI USA Small-Cap Multifactor ETF | 86.56 | 14.57 | 20.25% | |
| VIOO | Vanguard S&P Small-Cap 600 ETF | 132.41 | 25.05 | 23.34% | |
| CALF | Pacer US Small Cap Cash Cows 100 ETF | 58.22 | 15.16 | 35.21% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.